Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Outlook , 2030
The Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market is expected to grow at more than 5.2% CAGR.
- Bonafide Trust
- 28-06-2024
- Pages : 114
- Figures : 81
- Tables : 137
- Region : Global
- Category : Lifescience & Healthcare
- Medical Devices
The global diabetes management market, specifically focusing on insulin pumps and continuous glucose monitors (CGMs), is experiencing notable growth driven by several factors. This market encompasses advanced technologies that aid in the management of diabetes, particularly for patients requiring insulin therapy.Despite the positive outlook, the market faces challenges such as the high cost of insulin pumps and CGMs, which may limit accessibility for some patients, particularly in low and middle-income countries. CGM devices are minimally invasive and offer an easy and effective way to manage diabetes. They can also detect drastic changes in blood glucose levels, thereby preventing hypoglycemic conditions. The CGM devices facilitate the analysis of blood glucose levels at different time intervals with the help of a sensor. Respective readings fed into the diabetes management software through a wireless network allow patients to understand the disease better, thereby helping them to manage it in a more effective way. Smoking, obesity, physical inactivity, high blood pressure, and high cholesterol are the common risk factors associated with diabetes complications.
According to the research report "Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Outlook, 2030 " published by Bonafide Research, Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market is anticipated to grow at more than 5.2% CAGR from 2024 to 2030. The increasing prevalence of diabetes, particularly type 1 and type 2 diabetes, is a primary driver of this growth. The integration of advanced technologies such as artificial intelligence (AI) and machine learning (ML) into these devices is enhancing their functionality and user-friendliness, making them more appealing to patients and healthcare providers.The increasing incidence of prediabetes is also fueling the market growth. Prediabetes is a condition in which sugar levels in blood are higher than normal but not high enough to be classified as type 2 diabetes. It is a serious health condition that can increase the risk of developing type 2 diabetes, heart disease, and stroke. Unfortunately, the number of people diagnosed with prediabetes is rapidly growing. The main reason for the increase in prediabetes cases is the rise in obesity rates. Obesity is a major risk factor for developing prediabetes and type 2 diabetes. As more and more people adopt a sedentary lifestyle and consume unhealthy diet, the prevalence of obesity increases, which in turn leads to a rise in prediabetes cases. As a result, the market is expected to significantly grow in the coming years due to the increasing prevalence of diabetes and the growing need for better disease management tools.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Dynamics
Market Drivers
• Rising Prevalence of Diabetes : The increasing incidence of diabetes worldwide is a primary driver of market growth. According to the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021, a number projected to rise to 642 million by 2040. This surge is largely attributed to factors such as obesity, sedentary lifestyles, and aging populations. The World Health Organization highlights that diabetes is a leading cause of serious health complications, including heart disease and kidney failure. As awareness of diabetes management improves, more patients are seeking effective treatment options, including insulin pumps and CGMs. This growing demand is prompting healthcare providers and manufacturers to invest in innovative technologies to enhance patient outcomes and improve quality of life, thereby driving market expansion significantly.
• Technological Advancements : Technological innovations are reshaping the insulin pump and CGM landscape, making these devices more effective and user-friendly. The integration of features such as continuous glucose monitoring, automated insulin delivery, and smartphone connectivity is enhancing patient engagement and compliance. Companies are developing next-generation insulin pumps equipped with advanced algorithms and artificial intelligence, allowing for personalized insulin delivery that adjusts based on real-time glucose levels. These advancements not only improve the accuracy of diabetes management but also enhance the overall user experience, encouraging more patients to adopt these technologies. As manufacturers continue to innovate and introduce new products, the market is expected to see sustained growth, driven by both consumer demand and competitive pressure to deliver cutting-edge solutions.
Market Challenges
• High Cost of Insulin Pumps : The high cost of insulin pumps presents a substantial barrier to market growth. These devices typically require significant investment in research and development, resulting in high retail prices that many patients cannot afford. For instance, the average price of an insulin pump can range from $4,000 to $7,000, not including ongoing costs for supplies and maintenance. This financial burden restricts access for a large segment of the diabetic population, particularly in low- and middle-income countries. Additionally, the limited number of manufacturers allows for less competitive pricing, further exacerbating the issue. As a result, many patients continue to rely on traditional insulin delivery methods, which may not provide optimal diabetes management, thus limiting the potential market for insulin pumps and CGMs.
• Lack of Insurance Coverage or Reimbursement Policies : The absence of comprehensive insurance coverage and reimbursement policies for insulin pumps and CGMs is another critical challenge. Many health insurance plans do not fully cover the costs associated with these devices, leading to significant out-of-pocket expenses for patients. This lack of financial support discourages individuals from investing in advanced diabetes management technologies, particularly those who may benefit the most from them. Furthermore, the variability in coverage across different regions and insurance providers creates confusion and inconsistency in access to these essential medical devices. Without adequate insurance support, the adoption of insulin pumps and CGMs remains limited, hindering overall market growth and patient outcomes.
Market Trends
• Increasing Adoption of Patch Pumps : Patch pumps are gaining popularity due to their compact size, discrete design, and ease of use. These pumps are attached to the skin with an adhesive and require less supervision compared to traditional insulin pumps. Patch pumps often have built-in calculators that help determine the precise amount of insulin needed, reducing the risk of insulin overdose. The global insulin pump market share for patch pumps was around 37% in 2022, and this segment is expected to grow at a CAGR of 10% during the forecast period. The convenience and improved user experience offered by patch pumps are driving their adoption, particularly among younger patients who value discretion and simplicity in their diabetes management devices.
• Integration of AI and ML Technologies : Artificial intelligence and machine learning are being increasingly integrated into insulin pumps and CGMs to enhance their functionality and personalize diabetes management. Advanced algorithms can analyze real-time glucose data and adjust insulin delivery accordingly, providing more precise and effective treatment. AI-powered insulin pumps can also learn from a patient's habits and preferences, optimizing insulin delivery over time. This integration of intelligent technologies is expected to drive opportunities in the insulin pump market, particularly for type 2 diabetes management. As patients and healthcare providers recognize the benefits of automated insulin delivery systems, the demand for AI-enabled insulin pumps is likely to increase, fueling market growth.
End User :
• Patient Preferences : Patients with diabetes are the primary end users of insulin pumps and CGMs. Their preferences and expectations play a crucial role in driving market growth and adoption of these technologies. Patients seek devices that are comfortable, discreet, and easy to use, with features like wireless connectivity and waterproofing being highly desirable. They also value devices that provide better glycemic control and reduce the burden of diabetes management without compromising their quality of life. Customization options that allow patients to tailor the device features to their lifestyle are also important considerations. As patients become more informed about the potential benefits of insulin pumps and CGMs, their interest in trying these systems is expected to increase, provided the devices meet their psychosocial needs and expectations.
• Healthcare Provider Recommendations : Healthcare providers, including endocrinologists, diabetologists, and diabetes educators, are influential in recommending insulin pumps and CGMs to their patients. Their preferences are shaped by factors such as device accuracy, reliability, and ease of use. Providers prioritize technologies that can improve patient outcomes, reduce the risk of complications, and enhance the overall management of diabetes. They also consider the compatibility of insulin pumps and CGMs with their patients' lifestyles and their ability to integrate seamlessly into the patient's daily routine. As healthcare providers gain more experience with these technologies and observe their benefits in improving patient outcomes, their recommendations will continue to drive the adoption of insulin pumps and CGMs in the management of diabetes.
Segmentation Analysis
Based on the report the product type is segmented into Insulin Pump , Continuous Glucose Monitors (CGM)
Insulin pumps are compact, computerized devices designed to deliver precise doses of insulin continuously throughout the day. They come in two main types: tethered pumps, which are connected to the body via tubing, and patch pumps, which adhere directly to the skin without external tubing. The demand for insulin pumps is driven by their ability to provide consistent insulin delivery, reducing the frequency of injections and improving overall glycemic control. As diabetes prevalence rises—projected to reach 643 million by 2030—more patients are transitioning from traditional injection methods to insulin pumps for their convenience and effectiveness. The patch pump segment, in particular, is expected to see rapid growth, with a projected CAGR of 10% due to its discreet design and ease of use.Continuous Glucose Monitors (CGMs) are devices that track glucose levels in real-time, providing valuable data to patients and healthcare providers. CGMs consist of a small sensor placed under the skin, which measures glucose levels and transmits the data to a display device. The increasing adoption of CGMs is fueled by their ability to provide continuous glucose readings, helping users make informed decisions about their insulin dosing and lifestyle choices. This technology is particularly beneficial for patients with type 1 diabetes and those with type 2 diabetes who require insulin therapy. The demand for CGMs is expected to grow significantly as awareness of their benefits increases, alongside advancements in technology that enhance accuracy and user experience.
based on the report the product is segmented into Child , Adult , Elderly
The use of insulin pumps and CGMs in children with diabetes is crucial for managing their condition effectively. These devices offer several benefits, such as improved glycemic control, reduced risk of hypoglycemia, and enhanced flexibility in managing their diabetes around school activities and social events. Insulin pumps designed for children often feature smaller sizes, user-friendly interfaces, and durable designs to withstand the active lifestyles of young patients. The adult population, particularly those with type 1 diabetes and insulin-dependent type 2 diabetes, represents a significant segment of the insulin pump and CGM market. Adults often seek devices that offer advanced features, such as wireless connectivity, remote monitoring, and compatibility with smartphone apps. The demand for insulin pumps and CGMs among adults is driven by their desire to achieve better glycemic control, reduce the risk of complications, and maintain an active lifestyle. The elderly population, often with multiple comorbidities and complex diabetes management needs, is another important segment of the insulin pump and CGM market. Insulin pumps designed for the elderly often prioritize ease of use, with features such as simplified interfaces and reduced programming steps.
Regional Analysis
North America leads the market with advanced technology and high prevalence rates, Asia-Pacific shows significant growth potential due to rising diabetes awareness.
Europe balances innovation with regulatory challenges, while Latin America and the Middle East & Africa present opportunities tempered by economic and infrastructural barriers.The Middle East & Africa region faces significant challenges, including limited healthcare access and high device costs. However, there is a growing awareness of diabetes management, leading to increased demand for insulin pumps and CGMs.In Latin America, the insulin pump and CGM market is growing, but the adoption rate is slower compared to North America and Europe. Europe is also a significant market, characterized by a strong emphasis on healthcare innovation and patient-centric solutions.
Key Developments
• March 2019: The FDA approved the Medtronic MiniMed 670G, the first hybrid closed-loop insulin delivery system, which integrates continuous glucose monitoring with automated insulin delivery. This marked a significant advancement in diabetes management, allowing for improved glycemic control.
• September 2020: Tandem Diabetes Care launched the t:slim X2 insulin pump with Control-IQ technology, which automatically adjusts insulin delivery based on CGM readings. This innovation provided users with enhanced control over their blood glucose levels and reduced the burden of manual insulin adjustments.
• July 2021: Ysomed AG upgraded its my life YpsoPump system, enhancing its features and integrating with the Dexcom G6 CGM. This collaboration allowed users to manage their diabetes therapy via a smartphone app, showcasing the trend towards digital health solutions in diabetes management.
• May 2021: Roche introduced MySugr Pump Control, enabling patients to operate their insulin pumps directly from their smartphones. This development reflects the increasing consumer preference for user-friendly and connected diabetes management solutions.
• October 2022: The launch of the iLet Bionic Pancreas, an automated insulin delivery system, marked a significant milestone in diabetes technology. This system simplifies insulin administration for type 1 diabetes patients, demonstrating the ongoing evolution towards more automated and user-friendly devices.
• June 2023: Abbott announced the launch of the FreeStyle Libre 3, an advanced CGM system that provides real-time glucose readings with improved accuracy and a smaller sensor size. This development emphasizes the trend towards more compact and efficient monitoring solutions in diabetes care.
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Annual Sales 2019-2030
- 2.1.2 World Current & Future Analysis for Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) by Geographic Region, 2019, 2023 & 2030
- 2.1.3 World Current & Future Analysis for Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) by Country/Region, 2019, 2023 & 2030
- 2.2 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Segment by Type
- 2.2.1 Insulin Pump
- 2.2.2 Continuous Glucose Monitors (CGM)
- 2.3 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type
- 2.3.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type (2019-2024)
- 2.3.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue and Market Share by Type (2019-2024)
- 2.3.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sale Price by Type (2019-2024)
- 2.4 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Segment by Application
- 2.4.1 Child
- 2.4.2 Adult
- 2.4.3 Elderly
- 2.5 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application
- 2.5.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sale Market Share by Application (2019-2024)
- 2.5.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue and Market Share by Application (2019-2024)
- 2.5.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sale Price by Application (2019-2024)
- 3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) by Company
- 3.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Breakdown Data by Company
- 3.1.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Annual Sales by Company (2019-2024)
- 3.1.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Company (2019-2024)
- 3.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Annual Revenue by Company (2019-2024)
- 3.2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Company (2019-2024)
- 3.2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Company (2019-2024)
- 3.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sale Price by Company
- 3.4 Key Manufacturers Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Location Distribution
- 3.4.2 Players Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
- 4 World Historic Review for Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) by Geographic Region
- 4.1 World Historic Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Geographic Region (2019-2024)
- 4.1.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Annual Sales by Geographic Region (2019-2024)
- 4.1.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Annual Revenue by Geographic Region (2019-2024)
- 4.2 World Historic Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Country/Region (2019-2024)
- 4.2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Annual Sales by Country/Region (2019-2024)
- 4.2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Annual Revenue by Country/Region (2019-2024)
- 4.3 Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Growth
- 4.4 APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Growth
- 4.5 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Growth
- 4.6 Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Growth
- 5 Americas
- 5.1 Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country
- 5.1.1 Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2019-2024)
- 5.1.2 Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2019-2024)
- 5.2 Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type
- 5.3 Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Region
- 6.1.1 APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Region (2019-2024)
- 6.1.2 APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Region (2019-2024)
- 6.2 APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type
- 6.3 APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
- 7 Europe
- 7.1 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) by Country
- 7.1.1 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2019-2024)
- 7.1.2 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2019-2024)
- 7.2 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type
- 7.3 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) by Country
- 8.1.1 Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2019-2024)
- 8.1.2 Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2019-2024)
- 8.2 Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type
- 8.3 Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
- 10.3 Manufacturing Process Analysis of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
- 10.4 Industry Chain Structure of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
- 11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Distributors
- 11.3 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Customer
- 12 World Forecast Review for Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) by Geographic Region
- 12.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size Forecast by Region
- 12.1.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Forecast by Region (2025-2030)
- 12.1.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Annual Revenue Forecast by Region (2025-2030)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Forecast by Type
- 12.7 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Forecast by Application
- 13 Key Players Analysis
- 13.1 Abbott Laboratories
- 13.1.1 Abbott Laboratories Company Information
- 13.1.2 Abbott Laboratories Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
- 13.1.3 Abbott Laboratories Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.1.4 Abbott Laboratories Main Business Overview
- 13.1.5 Abbott Laboratories Latest Developments
- 13.2 Dexcom
- 13.2.1 Dexcom Company Information
- 13.2.2 Dexcom Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
- 13.2.3 Dexcom Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.2.4 Dexcom Main Business Overview
- 13.2.5 Dexcom Latest Developments
- 13.3 GlySens Incorporated
- 13.3.1 GlySens Incorporated Company Information
- 13.3.2 GlySens Incorporated Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
- 13.3.3 GlySens Incorporated Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.3.4 GlySens Incorporated Main Business Overview
- 13.3.5 GlySens Incorporated Latest Developments
- 13.4 Insulet Corp
- 13.4.1 Insulet Corp Company Information
- 13.4.2 Insulet Corp Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
- 13.4.3 Insulet Corp Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.4.4 Insulet Corp Main Business Overview
- 13.4.5 Insulet Corp Latest Developments
- 13.5 Johnson & Johnson
- 13.5.1 Johnson & Johnson Company Information
- 13.5.2 Johnson & Johnson Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
- 13.5.3 Johnson & Johnson Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.5.4 Johnson & Johnson Main Business Overview
- 13.5.5 Johnson & Johnson Latest Developments
- 13.6 Medtronic
- 13.6.1 Medtronic Company Information
- 13.6.2 Medtronic Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
- 13.6.3 Medtronic Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.6.4 Medtronic Main Business Overview
- 13.6.5 Medtronic Latest Developments
- 13.7 Meiqi Medical Equipment
- 13.7.1 Meiqi Medical Equipment Company Information
- 13.7.2 Meiqi Medical Equipment Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
- 13.7.3 Meiqi Medical Equipment Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.7.4 Meiqi Medical Equipment Main Business Overview
- 13.7.5 Meiqi Medical Equipment Latest Developments
- 13.8 Microport
- 13.8.1 Microport Company Information
- 13.8.2 Microport Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
- 13.8.3 Microport Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.8.4 Microport Main Business Overview
- 13.8.5 Microport Latest Developments
- 13.9 Roche
- 13.9.1 Roche Company Information
- 13.9.2 Roche Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
- 13.9.3 Roche Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.9.4 Roche Main Business Overview
- 13.9.5 Roche Latest Developments
- 13.10 Senseonics Holdings
- 13.10.1 Senseonics Holdings Company Information
- 13.10.2 Senseonics Holdings Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
- 13.10.3 Senseonics Holdings Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.10.4 Senseonics Holdings Main Business Overview
- 13.10.5 Senseonics Holdings Latest Developments
- 13.11 SOOIL
- 13.11.1 SOOIL Company Information
- 13.11.2 SOOIL Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
- 13.11.3 SOOIL Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.11.4 SOOIL Main Business Overview
- 13.11.5 SOOIL Latest Developments
- 13.12 Tandem Diabetes care
- 13.12.1 Tandem Diabetes care Company Information
- 13.12.2 Tandem Diabetes care Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
- 13.12.3 Tandem Diabetes care Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.12.4 Tandem Diabetes care Main Business Overview
- 13.12.5 Tandem Diabetes care Latest Developments
- 14 Research Findings and Conclusion
List of Tables
Table 1. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Insulin Pump
Table 4. Major Players of Continuous Glucose Monitors (CGM)
Table 5. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2019-2024) & (K Units)
Table 6. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type (2019-2024)
Table 7. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Type (2019-2024) & ($ million)
Table 8. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Type (2019-2024)
Table 9. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2019-2024) & (K Units)
Table 11. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Application (2019-2024)
Table 12. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Application (2019-2024)
Table 13. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Application (2019-2024)
Table 14. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Company (2019-2024) & (K Units)
Table 16. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Company (2019-2024)
Table 17. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Company (2019-2024)
Table 19. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Producing Area Distribution and Sales Area
Table 21. Players Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Products Offered
Table 22. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share Geographic Region (2019-2024)
Table 27. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Country/Region (2019-2024)
Table 31. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2019-2024) & (K Units)
Table 34. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Country (2019-2024)
Table 35. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Country (2019-2024)
Table 37. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2019-2024) & (K Units)
Table 38. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2019-2024) & (K Units)
Table 39. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Region (2019-2024) & (K Units)
Table 40. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Region (2019-2024)
Table 41. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Region (2019-2024)
Table 43. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2019-2024) & (K Units)
Table 44. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2019-2024) & (K Units)
Table 45. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2019-2024) & (K Units)
Table 46. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Country (2019-2024)
Table 47. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Country (2019-2024)
Table 49. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2019-2024) & (K Units)
Table 50. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
Table 58. Key Market Challenges & Risks of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
Table 59. Key Industry Trends of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
Table 60. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Distributors List
Table 63. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Customer List
Table 64. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Abbott Laboratories Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Laboratories Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 80. Abbott Laboratories Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Abbott Laboratories Main Business
Table 82. Abbott Laboratories Latest Developments
Table 83. Dexcom Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 84. Dexcom Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 85. Dexcom Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Dexcom Main Business
Table 87. Dexcom Latest Developments
Table 88. GlySens Incorporated Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 89. GlySens Incorporated Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 90. GlySens Incorporated Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. GlySens Incorporated Main Business
Table 92. GlySens Incorporated Latest Developments
Table 93. Insulet Corp Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 94. Insulet Corp Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 95. Insulet Corp Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Insulet Corp Main Business
Table 97. Insulet Corp Latest Developments
Table 98. Johnson & Johnson Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 99. Johnson & Johnson Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 100. Johnson & Johnson Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Johnson & Johnson Main Business
Table 102. Johnson & Johnson Latest Developments
Table 103. Medtronic Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 104. Medtronic Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 105. Medtronic Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Medtronic Main Business
Table 107. Medtronic Latest Developments
Table 108. Meiqi Medical Equipment Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 109. Meiqi Medical Equipment Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 110. Meiqi Medical Equipment Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Meiqi Medical Equipment Main Business
Table 112. Meiqi Medical Equipment Latest Developments
Table 113. Microport Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 114. Microport Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 115. Microport Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Microport Main Business
Table 117. Microport Latest Developments
Table 118. Roche Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 119. Roche Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 120. Roche Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Roche Main Business
Table 122. Roche Latest Developments
Table 123. Senseonics Holdings Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 124. Senseonics Holdings Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 125. Senseonics Holdings Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Senseonics Holdings Main Business
Table 127. Senseonics Holdings Latest Developments
Table 128. SOOIL Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 129. SOOIL Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 130. SOOIL Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. SOOIL Main Business
Table 132. SOOIL Latest Developments
Table 133. Tandem Diabetes care Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 134. Tandem Diabetes care Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 135. Tandem Diabetes care Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Tandem Diabetes care Main Business
Table 137. Tandem Diabetes care Latest Developments
Table 1. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Insulin Pump
Table 4. Major Players of Continuous Glucose Monitors (CGM)
Table 5. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2019-2024) & (K Units)
Table 6. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type (2019-2024)
Table 7. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Type (2019-2024) & ($ million)
Table 8. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Type (2019-2024)
Table 9. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2019-2024) & (K Units)
Table 11. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Application (2019-2024)
Table 12. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Application (2019-2024)
Table 13. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Application (2019-2024)
Table 14. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Company (2019-2024) & (K Units)
Table 16. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Company (2019-2024)
Table 17. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Company (2019-2024)
Table 19. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Producing Area Distribution and Sales Area
Table 21. Players Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Products Offered
Table 22. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share Geographic Region (2019-2024)
Table 27. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Country/Region (2019-2024)
Table 31. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2019-2024) & (K Units)
Table 34. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Country (2019-2024)
Table 35. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Country (2019-2024)
Table 37. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2019-2024) & (K Units)
Table 38. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2019-2024) & (K Units)
Table 39. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Region (2019-2024) & (K Units)
Table 40. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Region (2019-2024)
Table 41. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Region (2019-2024)
Table 43. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2019-2024) & (K Units)
Table 44. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2019-2024) & (K Units)
Table 45. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2019-2024) & (K Units)
Table 46. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Country (2019-2024)
Table 47. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Country (2019-2024)
Table 49. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2019-2024) & (K Units)
Table 50. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
Table 58. Key Market Challenges & Risks of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
Table 59. Key Industry Trends of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
Table 60. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Distributors List
Table 63. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Customer List
Table 64. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Abbott Laboratories Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Laboratories Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 80. Abbott Laboratories Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Abbott Laboratories Main Business
Table 82. Abbott Laboratories Latest Developments
Table 83. Dexcom Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 84. Dexcom Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 85. Dexcom Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Dexcom Main Business
Table 87. Dexcom Latest Developments
Table 88. GlySens Incorporated Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 89. GlySens Incorporated Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 90. GlySens Incorporated Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. GlySens Incorporated Main Business
Table 92. GlySens Incorporated Latest Developments
Table 93. Insulet Corp Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 94. Insulet Corp Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 95. Insulet Corp Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Insulet Corp Main Business
Table 97. Insulet Corp Latest Developments
Table 98. Johnson & Johnson Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 99. Johnson & Johnson Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 100. Johnson & Johnson Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Johnson & Johnson Main Business
Table 102. Johnson & Johnson Latest Developments
Table 103. Medtronic Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 104. Medtronic Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 105. Medtronic Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Medtronic Main Business
Table 107. Medtronic Latest Developments
Table 108. Meiqi Medical Equipment Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 109. Meiqi Medical Equipment Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 110. Meiqi Medical Equipment Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Meiqi Medical Equipment Main Business
Table 112. Meiqi Medical Equipment Latest Developments
Table 113. Microport Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 114. Microport Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 115. Microport Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Microport Main Business
Table 117. Microport Latest Developments
Table 118. Roche Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 119. Roche Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 120. Roche Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Roche Main Business
Table 122. Roche Latest Developments
Table 123. Senseonics Holdings Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 124. Senseonics Holdings Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 125. Senseonics Holdings Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Senseonics Holdings Main Business
Table 127. Senseonics Holdings Latest Developments
Table 128. SOOIL Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 129. SOOIL Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 130. SOOIL Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. SOOIL Main Business
Table 132. SOOIL Latest Developments
Table 133. Tandem Diabetes care Basic Information, Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 134. Tandem Diabetes care Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Portfolios and Specifications
Table 135. Tandem Diabetes care Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Tandem Diabetes care Main Business
Table 137. Tandem Diabetes care Latest Developments
List of Figures
Figure 1. Picture of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
Figure 2. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Insulin Pump
Figure 10. Product Picture of Continuous Glucose Monitors (CGM)
Figure 11. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type in 2023
Figure 12. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Type (2019-2024)
Figure 13. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Consumed in Child
Figure 14. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market: Child (2019-2024) & (K Units)
Figure 15. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Consumed in Adult
Figure 16. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market: Adult (2019-2024) & (K Units)
Figure 17. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Consumed in Elderly
Figure 18. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market: Elderly (2019-2024) & (K Units)
Figure 19. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Application (2023)
Figure 20. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Application in 2023
Figure 21. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market by Company in 2023 (K Units)
Figure 22. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Company in 2023
Figure 23. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Company in 2023
Figure 25. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales 2019-2024 (K Units)
Figure 28. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue 2019-2024 ($ Millions)
Figure 29. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales 2019-2024 (K Units)
Figure 30. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue 2019-2024 ($ Millions)
Figure 31. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales 2019-2024 (K Units)
Figure 32. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue 2019-2024 ($ Millions)
Figure 35. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Country in 2023
Figure 36. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Country in 2023
Figure 37. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type (2019-2024)
Figure 38. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Application (2019-2024)
Figure 39. United States Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Region in 2023
Figure 44. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Regions in 2023
Figure 45. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type (2019-2024)
Figure 46. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Application (2019-2024)
Figure 47. China Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Country in 2023
Figure 55. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Country in 2023
Figure 56. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type (2019-2024)
Figure 57. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Application (2019-2024)
Figure 58. Germany Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Application (2019-2024)
Figure 67. Egypt Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) in 2023
Figure 73. Manufacturing Process Analysis of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
Figure 74. Industry Chain Structure of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
Figure 75. Channels of Distribution
Figure 76. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Forecast by Region (2025-2030)
Figure 77. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share Forecast by Application (2025-2030)
"
Figure 1. Picture of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
Figure 2. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Insulin Pump
Figure 10. Product Picture of Continuous Glucose Monitors (CGM)
Figure 11. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type in 2023
Figure 12. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Type (2019-2024)
Figure 13. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Consumed in Child
Figure 14. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market: Child (2019-2024) & (K Units)
Figure 15. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Consumed in Adult
Figure 16. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market: Adult (2019-2024) & (K Units)
Figure 17. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Consumed in Elderly
Figure 18. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market: Elderly (2019-2024) & (K Units)
Figure 19. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Application (2023)
Figure 20. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Application in 2023
Figure 21. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market by Company in 2023 (K Units)
Figure 22. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Company in 2023
Figure 23. Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Company in 2023
Figure 25. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales 2019-2024 (K Units)
Figure 28. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue 2019-2024 ($ Millions)
Figure 29. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales 2019-2024 (K Units)
Figure 30. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue 2019-2024 ($ Millions)
Figure 31. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales 2019-2024 (K Units)
Figure 32. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue 2019-2024 ($ Millions)
Figure 35. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Country in 2023
Figure 36. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Country in 2023
Figure 37. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type (2019-2024)
Figure 38. Americas Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Application (2019-2024)
Figure 39. United States Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Region in 2023
Figure 44. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Regions in 2023
Figure 45. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type (2019-2024)
Figure 46. APAC Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Application (2019-2024)
Figure 47. China Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Country in 2023
Figure 55. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Country in 2023
Figure 56. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type (2019-2024)
Figure 57. Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Application (2019-2024)
Figure 58. Germany Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Application (2019-2024)
Figure 67. Egypt Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) in 2023
Figure 73. Manufacturing Process Analysis of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
Figure 74. Industry Chain Structure of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
Figure 75. Channels of Distribution
Figure 76. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Forecast by Region (2025-2030)
Figure 77. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share Forecast by Application (2025-2030)
"
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (09 May, 2026)
- Notify To Team (09 May, 2026)
- Report updation (10 May, 2026)
- Report Quality Check (10 May, 2026)
- Report Dispatch (11 May, 2026)
- Hard Copy
Recently Viewed Products
Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Outlook , 2030
We are friendly and approachable, give us a call.